Chugai Seiyaku Kabushiki Kaisha

Koji Mizuno

Shun-ichi Hata

Yasuho Nishii

Minoru Shindo

Yasushi Murakami

Tamotsu Yamazaki

Takashi Matsuno

Kiyoshige Wakabayashi

Shigeru Takanashi

Motoharu Shiba

Shin-ichi Kaiho

Etsuko Mitsuishi

Takashi Mori

Isao Matsunaga

Yasuhiro Yamashita

Osamu Cynshi

Sakae Takaku

Teizo Shinozaki

Shun-Ichi Hata

Masuo Koizumi

Shigeyuki Kataoka

Eiichi Hoshino

Yoshiyuki Ohsugi

Masamitsu Honda

Yasuhisa Takeda

Masayoshi Ono

Morio Kakimoto

Fumiaki Matsuura

Mitsuru Tanemura

Yumiko Takeda

Akio Yoshida

Shinichi Kaiho

Mitsura Tanemura

Toshiaki Nakano

A pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis comprising a therapeutically effective amount of human erythropoietin (EPO) in a parenterally acceptable vehicle is disclosed. Human EPO may be extracted from human urine or also be prepared by expressing in a host cell the gene coding for the amino acid sequence of human EPO.

Pharmaceutical composition for the treatment of the anemia of rheumatoid

A treating agent whose effective ingredient is an anthranyl derivative of the formula: ##STR1## (wherein R.sub.1 and R.sub.2 may be the same or different and represent a hydrogen atom, a hydroxyl group, a lower alkoxy group, preferably C.sub.1 -C.sub.3 alkoxy group, a lower alkyl group, preferably C.sub.1 -C.sub.3 alkyl group, a nitro group or a halogen atom) is disclosed.

Pharmaceutical composition for treating transplanted tumor cells

An anti-peptic ulcer agent which contains as an active ingredient aminobenzoic acid compounds of the formula ##STR1## (wherein R.sub.1, R.sub.2, and R.sub.3 which may be the same or different represent a hydrogen atom, halogen atom, lower alkyl group or lower alkoxy group but they do not represent a hydrogen atom at the same time) or pharmaceutically acceptable salts thereof and a method of preventing or treating a human in need of said prevention or treatment an effective amount of said active ingredient are disclosed.

Anti-peptic ulcer agent

1,4,5,6-Tetrahydronicotinamide derivative represented by the formula: ##STR1## (wherein R is defined in the specification), a process of preparing the same and pharmaceutical composition containing the same are disclosed. The compound has action for suppressing aggregation of platelets, and antiinflammatory, antipyretic and analgesic actions.

Tetrahydronicotinamide derivative, pharmaceutical compositions and use

An aminobenzoic acid derivative represented by the formula ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are defined hereinbelow, which has excellent activity for improving liver function and for potentiating and normalizing immunity; a process for preparing the same; and a pharmaceutical composition containing the same are disclosed.

Novel aminobenzoic acid derivatives, process for preparing the same and

A pharmaceutical composition for reducing the alcohol content or slowing the rate of increase thereof in the blood and inhibiting the accumulation of neutral lipid in the liver containing a uridine diphosphate as an effective ingredient and a method of the use thereof are disclosed.

Method for treating alcoholism

A pharmaceutical composition for treating alcoholism containing a uridine diphosphate glucuronic acid as an effective ingredient and a method of the use thereof are disclosed.

Method of treating alcoholism

Phthalazine derivatives represented by the formula ##STR1## and salts thereof which are useful for a luminescence immuno assay, or a process for preparing the same are disclosed.

Phthalazine derivatives and salts thereof

Growing community of inventors

Tokorozawa, Japan

Koji Mizuno